LAUSR

HighlightsDiabetes mellitus include changes in immune response processes.High glucose in vitro does not change cell viability.High glucose may be sufficient to alter the in vitro mediators’ production.NO production is dose‐dependent in relation to the glucose concentrations. &NA; Diabetes mellitus (DM) is a metabolic disorder that results in the impairment of the metabolism of carbohydrates, proteins and lipids. It can give rise to various complications, mainly caused by chronic exposure of cells to high glucose concentrations, including changes in the immune response processes. The aim of this study was to verify the chemokine and cytokines production profile in the presence of different glucose concentrations and infection/inflammatory stimuli. To this end, cell viability and the production of chemokines, cytokines and nitric oxide (NO) were analyzed in RAW 264.7 cell culture. Results demonstrated that there was no change in cell viability after 6, 24 and 72 h. Different stimuli were unable to modify the monocyte chemoattractant protein (MCP)‐1 and tumor necrosis factor (TNF)‐&agr; production. Groups stimulated with lipopolysaccharides (LPS) and LPS and recombinant interferon (rIFN)‐&ggr; down‐regulated interleukin (IL)‐1&agr;, IL‐10 and IL‐12 and up‐regulated IL‐6 production. NO production maintained a pattern of increase, according to the increase in glucose concentrations, reaching its peak at 72 h. In summary, the results demonstrated that high glucose concentrations alone may be sufficient to alter the in vitro mediators’ production of RAW 264.7 cells.